CD8A and autoimmune thrombocytopenic purpura: Evidence of a T cell response separate from antibody-mediated autoimmunity was further shown in ITP patients who did not respond to the anti-CD20+ B cell-depleting antibody rituximab, in whom increased levels of splenic CD8+ Tc were detected (158).